PROTEKT THERAPEUTICS

protekt-therapeutics-logo

ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.

#SimilarOrganizations #People #Financial #Website #More

PROTEKT THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2015-12-01

Address:
Ness Ziona, HaMerkaz, Israel

Country:
Israel

Website Url:
http://www.protektx.com

Total Employee:
1+

Status:
Active

Contact:
+972-8-9553100

Email Addresses:
[email protected]

Total Funding:
4.1 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS


Similar Organizations

aviceda-therapeutics-logo

Aviceda Therapeutics

Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

Current Employees Featured

yotam-nisemblat_image

Yotam Nisemblat
Yotam Nisemblat Chief Executive Officer & Co-Founder @ Protekt Therapeutics
Chief Executive Officer & Co-Founder

Founder


yotam-nisemblat_image

Yotam Nisemblat

Investors List

rmgp-biopharma-investment-fund_image

RMGP Biopharma Investment Fund

RMGP Biopharma Investment Fund investment in Venture Round - Protekt Therapeutics

johnson-johnson-innovation-jjdc_image

Johnson & Johnson Innovation – JJDC

Johnson & Johnson Innovation – JJDC investment in Venture Round - Protekt Therapeutics

futurx_image

FutuRx

FutuRx investment in Venture Round - Protekt Therapeutics

bukwang-pharmaceutical-co_image

Bukwang Pharmaceutical Co

Bukwang Pharmaceutical Co investment in Venture Round - Protekt Therapeutics

fonds-de-solidarit-ftq_image

Fonds de solidarité FTQ

Fonds de solidarité FTQ investment in Venture Round - Protekt Therapeutics

takeda-ventures_image

Takeda Ventures

Takeda Ventures investment in Venture Round - Protekt Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Venture Round - Protekt Therapeutics

Official Site Inspections

http://www.protektx.com Semrush global rank: 10.21 M Semrush visits lastest month: 25

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Protekt Therapeutics"

Alzheimer’s disease drug | Protekt Therapeutics | Israel

Alzheimer’s Disease (AD) is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and, eventually, the ability to carry out the simplest tasks. In most people with AD, symptoms first appear in their mid …See details»

Protekt Therapeutics - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number +972-54-6491370 ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase …See details»

Yotam Nisemblat, MSc, MBA - ProteKtx

Yotam Nisemblat MSc MBA is CEO of Protektx Therapeutics and a leading Neurobiologist with specialization in neurodegenerative diseases, leading the development of Alzheimer’s Disease …See details»

Yotam Nisemblat - Founder & Chief Scientific Officer

‏CEO at ProteKt Therapeutics CSO X-tosis‏ · ‏Specialties: CNS, , Alzheimer's disease, Neuropathic Pain, Parkinson's Disease, Depression, Celiac …See details»

ProteKt Therapeutics - PitchBook

Www.protektx.com. Formerly Known As. MemoFit. Ownership Status. Acquired/Merged (Operating Subsidiary) Financing Status. Formerly VC-backed. Corporate Office. At: Eli, …See details»

Terms of Use - protektx.com

Dec 5, 2023 The Company respects the rights of the website's users. If you think that certain content published on the website harms or offends you in any way, you may contact the …See details»

ProteKt Therapeutics Ltd. - VentureRadar

ProteKt Therapeutics is a biotech company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of... ... Find out more about ...See details»

Accessibility Statement - ProteKtx

Dec 5, 2023 Email: [email protected]. Telephone: +972-54-6491370 Have you encountered a problem? Tell us! We try to keep and maintain our website and improve accessibility. If you …See details»

ProteKt Therapeutics Ltd. | F6S

Protektx.com. About ProteKt Therapeutics Ltd. ProteKt Therapeutics is a biotech company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of …See details»

ProteKt Therapeutics - Overview, News & Similar companies

View ProteKt Therapeutics (www.protektx.com) location in Central District, Israel , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»

Protekt Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...

Aug 17, 2024 Explore Protekt Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

Protekt Therapeutics - FutuRx

Www.protektx.com. TEAM. The Company is comprised of individuals with vast experience in the biotech industry, as well as academic leaders in the fields of neuroscience and computational chemistry. Tetsuyuki Maruyama: …See details»

Protekt Therapeutics | Ness Ziona - Facebook

Protekt Therapeutics, Ness Ziona. 33 likes. Protekt Therapeutics is a drug development company located in Ness Ziona in Israel, developing potent and...See details»

Protekt Therapeutics, engineering, Ness Ziona, Ilan Ramon, 2

Engineering Protekt Therapeutics at 2 Ilan Ramon Street, Central District, Ness Ziona, Israel, 74140, ☎️ +972 8 955 3218. Get directions in Yandex Maps.See details»

ProteKt Therapeutics Ltd. (ProteKt Therapeutics Ltd.) - 药物管线_专 …

智慧芽新药情报库是智慧芽专为生命科学人士构建的基于ai的创新药情报平台,助您全方位提升您的研发与决策效率。See details»

Athlete-Tested, Made In Texas Liquid Performance Supplements

Fuel your hydration, energy, sleep, and immune system. Protekt liquid supplements absorb better and work faster than powders with none of the mixing, powders, or mess. Veteran owned and operated. No sugar, calories, or artificial sweeteners. Make your water work harder. Shop now »See details»

ProteKt Therapeutics-动脉网

ProteKt Therapeutics开发用于治疗神经退行性疾病和神经炎症疾病的激酶PKR的强效选择性抑制剂。ProteKt Therapeutics通过应用独特的计算方法并在临床相关分析中验证抑制剂,发现并开 …See details»

Protekx Company Profile | Management and Employees List

Company Name. Protekx. Main Industry. Consumer Electronics & Computers Retail, Retail. Website. www.protekxusa.comSee details»

Prof. Kobi Rosenblum - ProteKtx

Professor of molecular and cellular mechanisms underlying learning and memory, University of Haifa, Israel; PhD in neurobiology, post-doctoral research with Prof T.V.P. Bliss, FRS at NIMR, …See details»

Garantex Cryptocurrency Exchange Disrupted in International …

Mar 7, 2025 Garantex Splash Page. In conjunction with the operation targeting Garantex, the Department also announced the unsealing of an indictment in the Eastern District of Virginia …See details»

linkstock.net © 2022. All rights reserved